Edwards Lifesciences 10K Form

Sell

23

EW
Edwards Lifesciences

Last Price:

66.48

Seasonality Move:

7.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-04-29	10Q	EW/Edwards Lifesciences Quarterly
2024-02-12	10K	EW/Edwards Lifesciences Annual
2023-10-27	10Q	EW/Edwards Lifesciences Quarterly
2023-07-28	10Q	EW/Edwards Lifesciences Quarterly
2023-04-28	10Q	EW/Edwards Lifesciences Quarterly
2023-02-13	10K	EW/Edwards Lifesciences Annual

Receive EW News And Ratings

See the #1 stock for the next 7 days that we like better than EW

EW Financial Statistics

Sales & Book Value

Annual Sales:	$6B
Cash Flow:	$286.1M
Price / Cash Flow:	0
Annual Sales:	$12.35
Price / Book:	5.47

Profitability

EPS (TTM):	6.93000
Net Income (TTM):	$4.16B
Gross Margin:	$4.63B
Return on Equity:	21.3%
Return on Assets:	43.13%

Edwards Lifesciences Earnings Forecast

Key Edwards Lifesciences Financial Ratios

The Gross Profit Margin over the past 25 years for EW is 77.02%.
The Selling, General & Administrative Expenses for EW have been equal to 30.39% of Gross Profit Margin.
The Research & Development expenses have been 17.85% of Revenue.
The Interest Expense is 1.25% of Operating Income.
The Net Earning history of EW is 23.35% of Total Revenues.
Per Share Earnings over the last 25 years have been positive in 17 years.

Edwards Lifesciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	S&P500
Industry:	Health Care Equipment & Supplies
Sector:	Health Care
Current Symbol:	EW
CUSIP:	28176E
Website:	edwards.com

Debt

Debt-to-Equity Ratio:	0.08
Current Ratio:	3.71
Quick Ratio:	2.32

Price-to-Earnings

Trailing P/E Ratio:	29.37
Forward P/E Ratio:	27.37

EW Technical Analysis vs Fundamental Analysis

Sell

23

Edwards Lifesciences (EW) is a Sell

Is Edwards Lifesciences a Buy or a Sell?

Edwards Lifesciences stock is rated a Sell
The current Edwards Lifesciences [EW] share price is $67.54. The Score for EW is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.